Clinical Trial Update: Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+ [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Realgar-Indigo Naturalis plus Imatinib to placebo plus Imatinib in adults with Philadelphia chromosome-positive chronic myeloid leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Compound Formula Realgar-Indigo Naturalis (Realgar-Indigo Naturalis)
• Imatinib (imatinib)

Snippet

Sponsor: Junmin Li | Conditions: Chronic Myelogenous Leukemia | Phase 3 | Status: SUSPENDED